Q1FY23 Quarterly Result Announced for Apollo Hospitals Enterprise Ltd.
Healthcare Facilities firm Apollo Hospitals Enterprise announced Q1FY23 Result : Q1FY23 Revenues at Rs. 3,796 crs Growth of 7% over Q4 FY22 EBITDA (Pre Apollo 247 ramp up costs) at Rs 626 crs Growth of 14% over Q4FY22 Apollo 247 operating costs of Rs 135 crs in Q1 FY23 vs. Rs 84 crs in Q4FY22 GMV of Apollo 247 at Rs 215 crs vs. Rs 177 crs in Q4FY22 On track to deliver 1500 crs. of GMV in FY22-23 EBITDA (Post Apollo 247 costs) at Rs.491 crs growth of 6% over Q4FY22 Reported PAT at Rs. 317 crs, after deferred tax reversal of Rs 147 crs Adjusted PAT at Rs 171 crs, compared to Rs 178 crs in Q4FY22 Diluted EPS of Rs.22.05 per share in Q1FY23 (not annualised) Dr Prathap C. Reddy, Chairman, Apollo Hospital Group said, "The first quarter of the new financial year has seen a definitive increase in the demand for non-CO VID health services and augurs well for growth this financial year. We have been able to serve a larger number of patients with non-communicable diseases (NCDs) and restore them to health. At the same time, our focus on preventive healthcare has continued to help patients manage chronic conditions and nip them in the bud. With the overall economy emerging from the shadow of the pandemic, we have seen people returning to office and life coming back to normaL However, we continue to maintain precautions against COVID and remain vigilant and prepared against new infections such as monkeypox, which has been declared as a global health emergency by the World Health Organisat/on. We are glad to report increased progress in our digital initiatives. Our cardiovascular risk assessment tool is now integrated with Singapore-based ConnectedLife 's digital wellness solutions and is an acknowledgement of our innovative work in preventive healthcare. We are the first system in Asia Pacific to be awarded three Stage 6 certifications for H/MSS (Healthcare In formation and Management Systems Society) digital maturity models and the second system in the world to be awarded a Stage 6 DIAM certification. The DIAM validation commended us for our use of biomarkers, molecular imaging, and mapping software. Our patient portal was commended as "one of the finest examples of patient communication" with multiple functionalities, including appointment setting, health monitoring and device integration capability. It is recognition such as this that continues to motivate us to grow our digital health capabilities and leverage the full potential of digital technology for the best patient outcomes. Our aim remains to empower our patients and encourage them to proactively manage their own health, a factor that is increasingly considered as vital to improve the quality of healthcare. Our digital prowess is also empowering our doctors with digital tools to help patients realize their health goals. We are a/so preparing to utilize the power of 5G in healthcare. 56 technology can provide a solid security foundation for sharing vital patient data remotely. We partnered with Airtel and CISCO on a use case of a 56 connected ambulance to showcase how 56 technology can virtually transport doctors into the Ambulance to provide critical care even as the patient is enroute to the hospital in an emergency. We are excited about our acquisition of the hospital asset in 6urgaon, and we look forward to taking our unique brand of world class clinical outcomes to the fast-growing and discerning city. All our centres of excellence are now performing effectively and efficiently with digitization integrated into the healthcare delivery ecosystem. Out digital healthcare services platform Apollo 24/7 is also progressing faster than planned, with our physical pharmacy network poised to touch 5000 stores. Apollo Hospitals is now well poised to grow across all verticals this year!." Result PDF12-08-2022
